IFP Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.8K | Sell |
587
-18
| -3% | -$606 | ﹤0.01% | 2550 |
|
|
2025
Q1 | $19.2K | Hold |
605
| – | – | ﹤0.01% | 2298 |
|
|
2024
Q4 | $23.5K | Sell |
605
-163
| -21% | -$6.33K | ﹤0.01% | 2174 |
|
|
2024
Q3 | $34.5K | Sell |
768
-29
| -4% | -$1.31K | ﹤0.01% | 1892 |
|
|
2024
Q2 | $33.3K | Hold |
797
| – | – | ﹤0.01% | 1841 |
|
|
2024
Q1 | $36.3K | Sell |
797
-83
| -9% | -$3.78K | ﹤0.01% | 1707 |
|
|
2023
Q4 | $40.7K | Hold |
880
| – | – | ﹤0.01% | 1621 |
|
|
2023
Q3 | $35.8K | Hold |
880
| – | – | ﹤0.01% | 1696 |
|
|
2023
Q2 | $42.7K | Buy |
880
+482
| +121% | +$23.4K | ﹤0.01% | 1676 |
|
|
2023
Q1 | $23.9K | Sell |
398
-147
| -27% | -$8.83K | ﹤0.01% | 1939 |
|
|
2022
Q4 | $33K | Sell |
545
-35
| -6% | -$2.12K | ﹤0.01% | 2525 |
|
|
2022
Q3 | $35K | Sell |
580
-61
| -10% | -$3.68K | ﹤0.01% | 2649 |
|
|
2022
Q2 | $38K | Hold |
641
| – | – | ﹤0.01% | 2349 |
|
|
2022
Q1 | $38K | Buy |
641
+201
| +46% | +$11.9K | ﹤0.01% | 2349 |
|
|
2021
Q4 | $36K | Sell |
440
-438
| -50% | -$35.8K | ﹤0.01% | 1651 |
|
|
2021
Q3 | $78K | Buy |
878
+640
| +269% | +$56.9K | ﹤0.01% | 1357 |
|
|
2021
Q2 | $23K | Buy |
238
+63
| +36% | +$6.09K | ﹤0.01% | 1866 |
|
|
2021
Q1 | $15K | Buy |
175
+150
| +600% | +$12.9K | ﹤0.01% | 1955 |
|
|
2020
Q4 | $2K | Hold |
25
| – | – | ﹤0.01% | 2591 |
|
|
2020
Q3 | $2K | Buy |
+25
| New | +$2K | ﹤0.01% | 2456 |
|